Print Save or Share

LANEIGE SATIN FINISH TWIN PACT NO. 13

Dosage form: powder
Ingredients: TITANIUM DIOXIDE 0.08mg in 1g, OCTINOXATE 0.06mg in 1g, ZINC OXIDE 0.0294mg in 1g
Labeler: AMOREPACIFIC
NDC Code: 43419-863

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

LANEIGE
SATIN FINISH TWIN PACT SPF 25 / PA++

Drug Facts

Active Ingredients
TITANIUM DIOXIDE8 %
ETHYLHEXYL METHOXYCINNAMATE6 %
ZINC OXIDE2.94 %

WARNINGS

For external use only.

When using this product, Keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash and irritation develops and lasts.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions
  1. Use after makeup base or foundation.
  2. Tip out the contents with your finger and place on the parts where you want to cover a little bit at a time. Tap it on the part where you want to camouflage.

Inactive Ingredients

TALC, POLYMETHYL METHACRYLATE, DIISOSTEARYL MALATE, ALUMINA, DIMETHICONE, TRIETHOXYCAPRYLYLSILANE, METHICONE, MAGNESIUM STEARATE, ALUMINUM STEARATE, ACRYLATES/TRIDECYL ACRYLATE/TRIETHOXYSILYLPROPYL METHACRYLATE/DIMETHICONE METHACRYLATE COPOLYMER, SYNTHETIC FLUORPHLOGOPITE, WATER, BUTYLENE GLYCOL, BEESWAX, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, INULIN LAURYL CARBAMATE, HYDROXYPROPYL BISPALMITAMIDE MEA, METHYLPARABEN, BUTYLPARABEN, FRAGRANCE, MICA, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77491, CI 77492, CI 77499), ULTRAMARINES (CI 77007)

13 g / 0.5 OZ. e

AMOREPACIFIC US INC.
270 Sylvan Ave. #255
Englewood Cliffs, NJ07632
MADE IN KOREA
(5240)

PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 13

LANEÍGE

SATIN FINISH TWIN PACT
SPF25 PA++

PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 21

LANEÍGE

SATIN FINISH TWIN PACT
SPF25 PA++

PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 23

LANEÍGE

SATIN FINISH TWIN PACT
SPF25 PA++

PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 25

LANEÍGE

SATIN FINISH TWIN PACT
SPF25 PA++

PRINCIPAL DISPLAY PANEL - 13 g Carton Label, No. 31

LANEÍGE

SATIN FINISH TWIN PACT
SPF25 PA++

LANEIGE SATIN FINISH TWIN PACT NO. 13 
titanium dioxide, octinoxate, and zinc oxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-863
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.08 mg  in 1 g
OCTINOXATE (OCTINOXATE) OCTINOXATE0.06 mg  in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.0294 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
TALC 
ALUMINUM OXIDE 
DIMETHICONE 
OCTYLTRIETHOXYSILANE 
MAGNESIUM STEARATE 
ALUMINUM STEARATE 
WATER 
BUTYLENE GLYCOL 
YELLOW WAX 
METHYLPARABEN 
BUTYLPARABEN 
MICA 
FERRIC OXIDE RED 
FERRIC OXIDE YELLOW 
FERROSOFERRIC OXIDE 
Packaging
#Item CodePackage Description
1NDC:43419-863-4013 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35212/01/2010
LANEIGE SATIN FINISH TWIN PACT NO. 21 
titanium dioxide, octinoxate, and zinc oxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-864
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.08 mg  in 1 g
OCTINOXATE (OCTINOXATE) OCTINOXATE0.06 mg  in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.0294 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
TALC 
ALUMINUM OXIDE 
DIMETHICONE 
OCTYLTRIETHOXYSILANE 
MAGNESIUM STEARATE 
ALUMINUM STEARATE 
WATER 
BUTYLENE GLYCOL 
YELLOW WAX 
METHYLPARABEN 
BUTYLPARABEN 
MICA 
FERRIC OXIDE RED 
FERRIC OXIDE YELLOW 
FERROSOFERRIC OXIDE 
Packaging
#Item CodePackage Description
1NDC:43419-864-4113 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35212/01/2010
LANEIGE SATIN FINISH TWIN PACT NO. 23 
titanium dioxide, octinoxate, and zinc oxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-865
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.08 mg  in 1 g
OCTINOXATE (OCTINOXATE) OCTINOXATE0.06 mg  in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.0294 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
TALC 
ALUMINUM OXIDE 
DIMETHICONE 
OCTYLTRIETHOXYSILANE 
MAGNESIUM STEARATE 
ALUMINUM STEARATE 
WATER 
BUTYLENE GLYCOL 
YELLOW WAX 
METHYLPARABEN 
BUTYLPARABEN 
MICA 
FERRIC OXIDE RED 
FERRIC OXIDE YELLOW 
FERROSOFERRIC OXIDE 
Packaging
#Item CodePackage Description
1NDC:43419-865-4213 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35212/01/2010
LANEIGE SATIN FINISH TWIN PACT NO. 25 
titanium dioxide, octinoxate, and zinc oxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-866
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.08 mg  in 1 g
OCTINOXATE (OCTINOXATE) OCTINOXATE0.06 mg  in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.0294 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
TALC 
ALUMINUM OXIDE 
DIMETHICONE 
OCTYLTRIETHOXYSILANE 
MAGNESIUM STEARATE 
ALUMINUM STEARATE 
WATER 
BUTYLENE GLYCOL 
YELLOW WAX 
METHYLPARABEN 
BUTYLPARABEN 
MICA 
FERRIC OXIDE RED 
FERRIC OXIDE YELLOW 
FERROSOFERRIC OXIDE 
Packaging
#Item CodePackage Description
1NDC:43419-866-4313 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35212/01/2010
LANEIGE SATIN FINISH TWIN PACT NO. 31 
titanium dioxide, octinoxate, and zinc oxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43419-867
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (TITANIUM DIOXIDE) TITANIUM DIOXIDE0.08 mg  in 1 g
OCTINOXATE (OCTINOXATE) OCTINOXATE0.06 mg  in 1 g
ZINC OXIDE (ZINC OXIDE) ZINC OXIDE0.0294 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
TALC 
ALUMINUM OXIDE 
DIMETHICONE 
OCTYLTRIETHOXYSILANE 
MAGNESIUM STEARATE 
ALUMINUM STEARATE 
WATER 
BUTYLENE GLYCOL 
YELLOW WAX 
METHYLPARABEN 
BUTYLPARABEN 
MICA 
FERRIC OXIDE RED 
FERRIC OXIDE YELLOW 
FERROSOFERRIC OXIDE 
Packaging
#Item CodePackage Description
1NDC:43419-867-4413 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35212/01/2010
Labeler - AMOREPACIFIC (687995683)
Establishment
NameAddressID/FEIOperations
AMOREPACIFIC687995683MANUFACTURE

Revised: 11/2010
Document Id: 2a43db72-7e0f-4bf2-b9e4-81ef73a2f989
Set id: 8d62178b-3abe-4824-b449-999421f2abe0
Version: 1
Effective Time: 20101115
 
AMOREPACIFIC

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web1)